Csimma Cristina's most recent trade in Palisade Bio Inc was a trade of 9,580 Common Stock Options done . Disclosure was reported to the exchange on Feb. 8, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Palisade Bio Inc | Cristina Csimma | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 9,580 | 9,580 | - | - | Common Stock Options | |
Palisade Bio Inc | Cristina Csimma | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 9,580 | 0 | - | - | Common Stock Options | |
Palisade Bio Inc | Cristina Csimma | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 6,980 | 0 | - | - | Restricted Stock Units | |
Palisade Bio Inc | Csimma Cristina | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 6,980 | 7,042 | - | 0 | Common Stock, par value $0.01 | |
Palisade Bio Inc | Cristina Csimma | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 6,880 | 0 | - | - | Common Stock Options | |
Palisade Bio Inc | Csimma Cristina | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 6,880 | 6,880 | - | - | Common Stock Options | |
Palisade Bio Inc | Cristina Csimma | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 5,820 | 12,862 | - | 0 | Common Stock, par value $0.01 | |
Palisade Bio Inc | Cristina Csimma | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 5,820 | 0 | - | - | Restricted Stock Units | |
Palisade Bio Inc | Cristina Csimma | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2023 | 9,580 | 9,580 | - | - | Common Stock Options | |
Palisade Bio Inc | Cristina Csimma | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2023 | 6,980 | 6,980 | - | - | Restricted Stock Units |